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Background: Streptococcus pneumoniae, a main causative agent associated with
invasive and non-invasive infection in elderly population, is a major global health problem.
After pneumococcal conjugate vaccines (PCV) and pneumococcal polysaccharide
vaccines (PPV) were introduced, the distribution of S. pneumoniae serotypes has
changed. There was currently limited data on epidemiology and status of antimicrobial
resistance of S. pneumoniae in Shanghai.
Objective: To determine the serotype distribution, antimicrobial susceptibility and
molecular epidemiology of S. pneumoniae isolated from adults in Shanghai.
Method: A total of 75 S. pneumoniae isolates consecutively collected from 2015 through
2017were serotyped by conventional multiplex-PCR. The antimicrobial susceptibility was
determined by broth microdilution method. The multilocus sequence type (MLST) was
performed to estimate the molecular epidemiology.
Results: The predominant serotypes among the isolates were 19F (20.00%),
3 (16.00%), 23F (9.33%), 14 (8.00%), and19A (5.33%). The prevalence of
pneumococcal strains with serotypes targeted by vaccines PCV7, PCV10, PCV13,
and PPV23 was 44, 45.33, 66.67, and 80%, respectively. Penicillin non-susceptible
S. pneumoniae (PNSSP) accounted for 16% of the isolates examined and
resistance to erythromycin, azithromycin, tetracycline, clindamycin, cefaclor and
trimethoprim-sulfamethoxazole were found in 92.00, 90.67, 86.67, 81.33, 54.67,
and 54.67% of isolates, with most isolates (78.67%) presenting multidrug-resistance.
The top three sequence types (STs) were ST271 (17.33%), ST180 (9.33%),
and ST81 (8.00%). The international resistance clone complexes Spain23F-1
(n = 4), Netherland3-31 (n = 8), and Taiwan19F-14 (n = 14) were identified.
Li et al. Epidemology of S. pneumoniae in Adults
Conclusions: The S. pneumoniae isolates showed high genetic diversity in Shanghai
and the prevalence of antimicrobial resistance was also high among S. pneumoniae
isolates, most of which were multidrug-resistant. The spread of international resistance
clones might contribute to the increase of resistant isolates. The PPV23 could protect
against most pneumococcal capsular serotypes causing infection of adults in Shanghai.
Keywords: Streptococcus pneumoniae, serotype distribution, antimicrobial susceptibility, molecular
epidemiology, pneumococcal pneumonia, pneumococcal conjugate vaccine
INTRODUCTION
Streptococcus pneumoniae is an opportunistic pathogen that
causes both invasive pneumococcal diseases (IPD) including
meningitis, bacteremia and non-invasive infection diseases such
as otitis media, sinusitis, pneumonia (Engholm et al., 2017). The
rate of IPD and the case fatality rate increased with increasing age.
Although only 27.3% of the cases were in those aged ≥ 65 years,
they accounted for 48% of the deaths (Marrie et al., 2018). The
burden of non-invasive pneumococcal disease in adults is mainly
determined by community-acquired pneumonia. Pneumococcal
pneumonia also shows high incidence rates and carries a high
mortality risk, especially in the elderly (Drijkoningen and Rohde,
2014). Chronic diseases and immunocompromise (IC), common
in elderly population, are considered as two important risk
factors in pneumococcal disease (PD) (Gil-Prieto et al., 2016).
It has been presented as a significant cause which leads to
substantial economic burden in at-risk and high-risk adults
(Zhang et al., 2018).
Vaccines targeting pneumococcus are beneficial to the
susceptible population. A study in the US reported that use of the
pneumococcal conjugate vaccines (PCV) among children since
2000 has dramatically reduced IPD burden among adults (Moore
et al., 2015; Pilishvili and Bennett, 2015). Multiple pneumococcal
conjugate vaccines (PCV) and pneumococcal polysaccharide
vaccines (PPV) have been developed and introduced to
numerous counties (Ochoa-Gondar et al., 2015; Akata et al.,
2017; Jauneikaite et al., 2017; Lyu et al., 2017). In China, the 7-
valent PCV were first licensed in 2008 and PCV13 and PPV23
are currently on the market (Liang et al., 2016). So far, they have
not been covered by the official mandatory vaccination system as
a secondary category vaccine. The vaccination is given only on
voluntary basis at own expense, which maybe the cause of low
vaccination rate in targeting population.
Antimicrobial is used as the most common anti-infection
therapy and beta-lactam antibiotic is the first choice for the
treatment of pneumococcal pneumonia. The increasing MIC
value of penicillin worldwide has been observed and high-level
cephalosporin-resistance caught most concern (Hakenbeck et al.,
2012). On the other hand, high resistance rate (over 90%)
of macrolide and clindamycin, tetracycline has been reported
frequently in both pediatric and adult patients in mainland of
China (Zhao et al., 2017; Wang et al., 2019). The resistance status
is an important reference for antimicrobial selection for anti-
infection therapy. The antibiotic-resistance varies in different
regions so that local drug resistance monitoring is essential to
provide evidence for clinical practice.
Surveillance of serotypes distribution and prevalence of
drug-resistance strains in general population is critical for
development of appropriate prevention and treatment protocol
for S. pneumoniae infection. Shanghai is one of the most densely-
populated municipals with more than two million people aging
over 65 years old. Although the serotype distribution of S.
pneumoniae and the status of antimicrobial resistance in children
has been reported in Shanghai, there has been only limited data
for adults in this area (Pan et al., 2015). This multicenter study
tried to survey the serotype distribution, antimicrobial resistance
and molecular epidemiology of S. pneumoniae among adults
in Shanghai.
MATERIALS AND METHODS
Patients and Clinical Isolates
The study was conducted at Ruijin Hospital, Renji Hospital and
Zhongshan Hospital, which are university-affiliated institutions
with over 2000 licensed beds. We performed a retrospective
lab-based study of adult patients (over 18 years old) with PD
between January 2015 and December of 2017. Cases of PD
were identified according to the database in the Department of
Clinical Microbiology of each hospital. If the strain was separated
from aseptic specimens such as blood and cerebrospinal fluid,
it was regarded as IPD. If the strain was separated from non-
aseptic specimens such as sputum, it was regarded as non-
IPD. Seventy-five episodes of PD were enrolled in this study,
only the first isolate of the same type of specimen from
the same patient was reviewed and recorded. On basis of
colony, microscopic morphology and the production of catalase,
optochin test (5 µg in a 6mm disk) was carried out to detect
the susceptibility of isolates. If the diameter was over 14mm, the
isolate was identified as S. pneumoniae. If the diameter ranged
from 9 to 13mm, bile-solute test was performed to identity the
isolate. Meanwhile, isolates enrolled were also identified using
matrix-assisted laser desorption ionization-time of flight mass
spectrometer (bioMérieux, Marcy-l’Étoile, France).
This study was approved by the Ethics Committee of Ruijin
Hospital affiliated with the School of Medicine at Shanghai Jiao
Tong University. The Review Board exempted requirement for
informed consent because this retrospective study used only the
bacterial samples and had no any negative impact on the patients.
Antimicrobial Susceptibility Tests
The minimum inhibitory concentrations (MICs) were
determined by microdilution method according to the
CLSI guideline (CLSI, 2015). Twenty antibiotics were
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tested (µg/mL): penicillin (0.015∼16); amoxillin/clavulanic
(0.06/0.03∼8/4), cefepime (0.03∼4), ceftriaxone (0.03∼4),
erythromycin (0.06∼8), clindamycin (0.03∼4), azithromycin
(0.06∼8), tetracycline (0.12∼16), meropenem (0.06∼8),
ertapenem (0.03∼4), imipenem (0.015∼2), moxifloxacin
(0.06∼8), trimethoprim/sulfamethoxazole (0.06/1.2∼8/152),
rifampin (0.03∼4), vancomycin (0.12∼16), cefaclor (0.25∼16),
levofloxacin (0.25∼16), linezolid (0.12∼8), chloramphenicol
(0.5∼32), cefuroxime (0.12∼8). The breakpoints used for
interpretation were recommended by CLSI guideline (CLSI,
2019). S. pneumoniae ATCC 49619 was used for quality control.
DNA Preparation
Rapid DNA extraction was performed by boiling 200µl of
bacteria suspension of 1.0 MCF for 10min. Then the suspension
was centrifuged at 12,000rpm/min for 10min. The supernatant
was transferred into a second sterile tube and stocked at −20◦C
until required.
Serotyping
Serotyping was performed by sequential multiplex-PCR and
primers targeting cpsA were used as a positive control in each
reaction (Pai et al., 2006). Serotype 6A and 6B were distinguished
as previously described (Jin et al., 2009). Serotype 2 and 9N/L
were identified by PCR according to previous reported (Dias
et al., 2007; da Gloria Carvalho et al., 2010). Other non-vaccine
serotypes were detected as published by the Centers for Disease
Control and Prevention (CDC)1. If serotype that could not
identified by conventional multiplex-PCR above, the isolate was
classified as untypeable. All primer pairs were listed in Table 1.
The prevalence of pneumococcal strains with serotypes targeted
by current vaccines were calculated by the percentage of the
isolates that the vaccines could protect against.
Multilocus Sequence Typing (MLST)
Seven housekeeping genes (aroE, gdh, gki, recP, spi, xpt, and
ddl) were amplified, sequenced, and analyzed. Alleles and
sequence types (STs) were determined according to the PubMLST
database (https://pubmlst.org/spneumoniae/). Sequence and STs
that could not be found in the database were submitted to the
curator of the database. The clustering of related STs was analyzed
by eBURST Version 3.0.
Statistical Analysis
Data in this study were analyzed by SAS 8.2 (SAS Institute
Inc., Cary, NC, USA). For categorical variables, such as rates
of antimicrobial resistance and serotype, the chiq-square test or
Fisher test was used to compare the disparity between different
groups. P < 0.05 was considered statistically significant.
RESULTS
Clinical Data
Seventy-five isolates were collected from January 2015 to
December of 2017 (Supplementary Table 1), more (65.33%)
were from male than female (34.67%). The age of those patients
1http://www.cdc.gov/streplab/pcr.html
TABLE 1 | Primer pairs of some serotypes in Streptococcus pneumoniae.
Serotype Primer sequence (5′-3′) Product
(bp)
1 F:CTCTATAGAATGGAGTATATAAACTATGGTTA 280
R:CCAAAGAAAATACTAACATTATCACAATATTGGC
2 F: TATCCCAGTTCAATATTTCTCCACTACACC 290
R: ACACAAAATATAGGCAGAGAGAGACTACT
3 F:ATGGTGTGATTTCTCCTAGATTGGAAAGTAG 371
R:CTTCTCCAATTGCTTACCAAGTGCAATAACG
4 F:CTGTTACTTGTTCTGGACTCTCGATAATTGG 430
R:GCCCACTCCTGTTAAAATCCTACCCGCATTG
5 F:ATACCTACACAACTTCTGATTATGCCTTTGTG 362
R:GCTCGATAAACATAATCAATATTTGAAAAAGTATG
6A/B F:AATTTGTATTTTATTCATGCCTATATCTGG 250
R:TTAGCGGAGATAATTTAAAATGATGACTA
6C/D F: CATTTTAGTGAAGTTGGCGGTGGAGTT 727
R: AGCTTCGAAGCCCATACTCTTCAATTA
7F F:CCTACGGGAGGATATAAAATTATTTTTGAG 826
R:CAAATACACCACTATAGGCTGTTGAGACTAAC
7C F:CTATCTCAGTCATCTATTGTTAAAGTTTACG
ACGGGA
260
R:GAACATAGATGTTGAGACATCTTTTGTAATTTC
8 F:GATGCCATGAATCAAGCAGTGGCTATAAATC 294
R:ATCCTCGTGTATAATTTCAGGTATGCCACC
9N/L F: GAACTGAATAAGTCAGATTTAATCAGC 516
R: ACCAAGATCTGACGGGCTAATCAAT
9V F:CTTCGTTAGTTAAAATTCTAAATTTTTCTAAG 753
R:GTCCCAATACCAGTCCTTGCAACACAAG
10A F:GGTGTAGATTTACCATTAGTGTCGGCAGAC 628
R:GAATTTCTTCTTTAAGATTCGGATATTTCTC
10F/10C/33C F:GGAGTTTATCGGTAGTGCTCATTTTAGCA 248
R:CTAACAAATTCGCAACACGAGGCAACA
11A F:GGACATGTTCAGGTGATTTCCCAATATAGTG 463
R:GATTATGAGTGTAATTTATTCCAACTTCTCCC
12F F:GCAACAAACGGCGTGAAAGTAGTTG 376
R:CAAGATGAATATCACTACCAATAACAAAAC
13 F:TACTAAGGTAATCTCTGGAAATCGAAAGG 655
R:CTCATGCATTTTATTAACCGCTTTTTGTTC
14 F:CTTGGCGCAGGTGTCAGAATTCCCTCTAC 208
R:GCCAAAATACTGACAAAGCTAGAATATAGCC
15A F:ATTAGTACAGCTGCTGGAATATCTCTTC 436
R:GATCTAGTGAACGTACTATTCCAAAC
15B/C F:TTGGAATTTTTTAATTAGTGGCTTACCTA 496
R:CATCCGCTTATTAATTGAAGTAATCTGAACC
16F F:CTGTTCAGATAGGCCATTTACAGCTTTAAATC 988
R:CATTCCTTTTGTATATAGTGCTAGTTCATCC
17F F:TTCGTGATGATAATTCCAATGATCAAACAAGAG 693
R:GATGTAACAAATTTGTAGCGACTAAGGTCTGC
18 F:CTTAATAGCTCTCATTATTCTTTTTTTAAGCC 573
R:TTATCTGTAAACCATATCAGCATCTGAAAC
19A F:GAGAGATTCATAATCTTGCACTTAGCCA 566
R:CATAATAGCTACAAATGACTCATCGCC
19F F:GTTAAGATTGCTGATCGATTAATTGATATCC 304
(Continued)
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TABLE 1 | Continued
Serotype Primer sequence (5′-3′) Product
(bp)
R:GTAATATGTCTTTAGGGCGTTTATGGCGATAG
20 F:GAGCAAGAGTTTTTCACCTGACAGCGAGAAG 514
R:CTAAATTCCTGTAATTTAGCTAAAACTCTTATC
21 F:CTATGGTTATTTCAACTCAATCGTCACC 192
R:GGCAAACTCAGACATAGTATAGCATAG
22F F:GAGTATAGCCAGATTATGGCAGTTTTATTGTC 643
R:CTCCAGCACTTGCGCTGGAAACAACAGACAAC
23A F:TATTCTAGCAAGTGACGAAGATGCG 722
R:CCAACATGCTTAAAAACGCTGCTTTAC
23B F:CCACAATTAGCGCTATATTCATTCAATCG 199
R:GTCCACGCTGAATAAAATGAAGCTCCG
23F F:GTAACAGTTGCTGTAGAGGGAATTGGCTTTTC 384
R:CACAACACCTAACACTCGATGGCTATATGATTC
24F/A/B F:GCTCCCTGCTATTGTAATCTTTAAAGAG 99
R:GTGTCTTTTATTGACTTTATCATAGGTCGG
31 F:GGAAGTTTTCAAGGATATGATAGTGGTGGTGC 701
R:CCGAATAATATATTCAATATATTCCTACTC
33F F:GAAGGCAATCAATGTGATTGTGTCGCG 338
R:CTTCAAAATGAAGATTATAGTACCCTTCTAC
34 F:GCTTTTGTAAGAGGAGATTATTTTCACCCAAC 408
R:CAATCCGACTAAGTCTTCAGTAAAAAACTTTAC
35A/C/42 F:ATTACGACTCCTTATGTGACGCGCATA 280
R:CCAATCCCAAGATATATGCAACTAGGTT
35B F:GATAAGTCTGTTGTGGAGACTTAAAAAGAATG 677
R:CTTTCCAGATAATTACAGGTATTCCTGAAGCAAG
35F F:GAACATAGTCGCTATTGTATTTTATTTAAAGCAA 517
R:GACTAGGAGCATTATTCCTAGAGCGAGTAAACC
38/25F/A F:CGTTCTTTTATCTCACTGTATAGTATCTTTATG 574
R:ATGTTTGAATTAAAGCTAACGTAACAATCC
39 F:TCATTGTATTAACCCTATGCTTTATTGGTG 98
R:GAGTATCTCCATTGTATTGAAATCTACCAA
cpsA F:GCAGTACAGCAGTTTGTTGGACTGACC 160
R:GAATATTTTCATTATCAGTCCCAGTC
ranged from 28 to 90 years old, of which the mean was 58y and
the median was 60 y. The proportion of patients aged over 65
was 37.33%. Among all isolates, 54 were from sputum specimen,
10 from blood and 4 from bronchial lavages and others were
from nasal swab, bile, pus, exudates, pleuroperitoneal fluids and
drainage-fluid (Figure 1), of which 21.33% were separated from
aseptic specimens regarded as invasion, 78.67% from non-aseptic
specimens regarded as non-invasion. The proportion of IPD in
patients over 65 years old (28.57%) was higher than that in the
younger group (17.02%). The common initial diseases in this
study was malignant tumor (28.00%) and diseases of respiratory
system (16.00%) (Table 2).
Serotype Distribution
Among the 75 S. pneumoniae isolates, 70 had been properly
serotyped. The other 5 isolates were classified as untypeable.
FIGURE 1 | Specimen types of 75 pneumococcal disease cases in Shanghai
from 2015 to 2017.
TABLE 2 | Clinical information of adult patient with PD in Shanghai.
19–64y (n = 47) >65y (n = 28) Total (n = 75)
n Proportion
(%)
n Proportion
(%)
n Proportion
(%)
Gender
Female 21 44.68 5 17.86 26 34.67
Male 26 55.32 23 82.14 49 65.33
PD
Invasive 8 17.02 8 28.57 16 21.33
Non-invasive 39 82.98 20 71.43 59 78.67
Initial diagnosis
Respiratory tract
infections
4 8.51 3 10.71 7 9.33
Pulmonary diseasesa 4 8.51 1 3.57 5 6.67
Malignant tumor 11 23.40 10 35.71 21 28.00
Cardio-
cerebrovascular
disease
5 10.64 2 7.14 7 9.33
Autoimmune disease 3 6.38 0 0.00 3 4.00
Othersb 3 6.38 7 25.00 10 13.33
Undiagnosed 17 36.17 5 17.86 22 29.33
Pulmonary diseasesa, including pulmonary space occupying lesion, pulmonary
sarcoidosis, bronchiectasia and chronic obstructive pulmonary disease.
Othersb, including hepatic cirrhosis, jaundice, nephropathy, myopathy, periarthritis,
cervical spondylopathy and fever.
Of the serotyped isolates, the most prevalent serotype was 19F
(20.00%), followed by 3 (16.00%), 23F (9.33%), 14 (8.00%),
and 19A (5.33%). The rates of strains targeted by PCV7,
PCV10, PCV13 and PPV23 were 44%, 45.33%, 66.67% and 80%,
respectively. The targeted rates in elderly patients (≥65 y) were
higher than those in younger patients, which both PCV7 and
PCV10 accounted for 64.29% (P = 0.0063, P = 0.0109), PCV13
for 75.01% (P = 0.2373), and PPV23 for 89.29% (P = 0.2101)
(Figure 2).
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FIGURE 2 | Serotype distribution of S. pneumoniae in adults and the coverage of current vaccines in mainland of China. NT, Untypeable by multiplex-PCR.
FIGURE 3 | Population snapshot of S. pneumoniae. The STs were displayed as a single eBURST diagram by setting the group definition of zero of seven shared
alleles. Each number represents one ST and the area of each circle indicates the prevalence of the ST in the MLST data of this study. All 44 STs were shown here in
only one group. MLST, Multilocus sequence typing; ST, Sequence type.
Antimicrobial Susceptibility
The rates of susceptible, intermediate and resistance of S.
pneumoniae islolates were listed in Table 3. According to the
parenteral breakpoint of CLSI guideline, no isolate was resistant
to penicillin (MIC ≥ 8µg/mL), and penicillin-intermediate S.
pneumoniae (PISP, MIC = 4µg/mL) accounted for 16.00% of
all isolates. For oral breakpoint, the resistant (MIC ≥ 2µg/mL)
and intermediate (MIC = 0.12–1µg/mL) rates were up to
42.67 and 9.33%, respectively. Most isolates (more than 80%)
were resistant to erythromycin, clindamycin, azithromycin, and
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tetracycline. The resistant rates of cefaclor, cefuroxime, and
trimethoprim/sulfamethoxazole were about 50%. There were
14.67 and 17.33% of all isolates resistant to cefepime and
ceftriaxone. In penicillin non-susceptible isolates (PNSSP, MIC
≥ 4µg/mL), the resistant rates of erythromycin, clindamycin,
azithromycin, tetracycline and trimethoprim/sulfamethoxazole
were 100%, which in PSSP were 90.47, 77.78, 88.89, 84.13,
and 46.03%, respectively. Most isolates (over 95.00%) were
susceptible to moxifloxacin, levofloxacin, chloramphenicol and
all isolates were susceptible to linezolid and vancomycin.
As described in Table 4, two thirds of serotype 19F isolates
were non-susceptible to penicillin and more resistant to
antibiotics than other serotypes. Moreover, serotype 23F, 14 and
19A showed high resistant rates of cefuroxime. Serotype 3 isolates
were more susceptible to these antibiotics than others. The rates
of resistance to cefuroxime, trimethoprim/sulfamethoxazole and
meropenem in PCV13 targeting isolates were significantly higher
than non-PCV13 isolates (the values of χ2were 16.67, 4.90,
and 7.41 respectively, P < 0.05). A similar phenomenon was
also observed in ceftriaxone and cefepime in PCV13 group
and non-PCV13 group (both χ2 = 13.61 P < 0.05). There
was no significant difference in erythromycin, clindamycin,
azithromycin, tetracycline and levofloxacin (P > 0.05).
The resistance patterns were shown in Table 5. Most
serotype 19F isolates were PNNSP and were resistance to
extensive beta-lactam antibiotics. The most extensive resistance
pattern was AMC-FEP-CRO-MEM-IPM-CEC-CXM. Isolates
with multidrug-resistance (MDR) accounted for 78.67% (59/75)
of all strains. The most common pattern macrolides (ERY and/or
AZM)-CLI-TCY existed in 74.67% (56/75) of isolates. The rate
of inducible resistance to clindamycin in erythromycin-resistant
isolates (n= 69) was 10.14% (n= 7).
MLST
Forty-four STs were identified by MLST analysis among 75
isolates. The most prevalent STs were ST271 (n = 13, 17.33%),
ST180 (n= 7, 9.33%), ST81 (n= 6, 8.00%). All ST271, ST876, and
ST320 isolates were serotyped as 19F, 14, and 19A, respectively.
Most of ST180 and ST81 related to serotype 3 and 23F (Table 5).
There were seven new ST isolates identified in current study,
which had received ST number (ST14603, ST14605, ST14606,
ST14607, ST14664, ST14665, and ST14697).
There were two clonal complexes (CC) which the primary
founders were ST271 with three single-locus variants (SLVs) and
ST180 with two SLVs (Figure 3). We defined a group as at least
six of seven MLST alleles in common. The ST4113 and ST14606
could be considered to belong to a single clonal complex, so could
ST1263 and ST280. And there was no SLV and DLV of ST81.
Compared with Pneumococcal Molecular Epidemiology
Network database (PMEN) (at least six of seven alleles in
common), there were 34.67% (26/75) of isolates assigned with
international resistance clone complexes and their SLVs. The
three international resistance clones were Spain23F-1 (n = 4),
Netherland3-31 (n= 8) and Taiwan19F-14 (n= 14). Furthermore,
Taiwan19F-14 clone included 2 STs, the one SLV (ST271, n= 13).
Netherland3-31 clone was also frequently identified in this study
TABLE 3 | Antimicrobial susceptibility of 75 S. pneumoniae isolates to 20
antimicrobial agents.
Antibioticsa S (%) I (%) R (%) MIC50 MIC90
PEN (parenteral breakpoint*) 84.00 16.00 0.00 0.25 4
PEN (oral breakpoint*) 48.00 9.33 42.67 0.25 4
AMC 74.67 6.67 18.67 0.25/0.12 4/8
FEP 65.33 20.00 14.67 0.125 4
CRO 65.33 17.33 17.33 0.125 4
ERY 8.00 0.00 92.00 >8 >8
CLI 18.67 0.00 81.33 >4 >4
AZM 8.00 1.33 90.67 >8 >8
TCY 10.67 2.67 86.67 >16 >16
MEM 52.00 22.67 25.33 0.12 1
ERT 73.33 26.67 0.00 0.25 2
IMP 50.67 40.00 9.33 0.06 0.5
MFX 97.33 1.33 1.33 0.12 0.25
SXT 37.33 8.00 54.67 4 8
RIF 100.00 0.00 0.00 ≤0.03 0.06
VAN 100.00 0.00 0.00 0.5 0.5
CEC 42.67 2.67 54.67 16 >16
LEV 96.00 0.00 4.00 1 1
LNZ 100.00 0.00 0.00 0.5 1
CHL 93.33 0.00 6.67 2 >4
CXM 49.33 1.33 49.33 0.5 >8
aPEN, penicillin; AMC, amoxillin/clavulanic; FEP, cefepime; CRO, ceftriaxone; ERY,
erythromycin; CLI, clindamycin; AZM, azithromycin; TCY, tetracycline; MEM, meropenem;
ERT, ertapenem; IMP, imipenem; MFX, moxifloxacin; SXT, trimethoprim/sulfamethoxazole;
RIF, rifampin; VAN, vancomycin; CEC, cefaclor; LEV, levofloxacin; LNZ, linazolid; CHL,
chloramphenicol; CXM, cefuroxime.
*There was no isolates separated from cerebrospinal fluid so that the all breakpoints were
chose for non-meningitis.
including 3 STs, the original Netherland3-31 ST180 (n = 6) and
two SLVs, ST8561 (n= 1) and ST3942 (n= 1).
DISCUSSION
S. pneumoniae is the principle pathogen that usually caused
respiratory infection and invasive infection in children under
five years old and senior citizen over 65 years old (Bogaert
et al., 2004). Generally, it colonizes the nasopharynx as part of
commensal flora in the health person. Once immune system is
weaken or ectopic infection occurs, it can caused pneumococcal
disease (Bogaert et al., 2004). IPD and pneumococcal pneumonia
are common and carry a significant morbidity and mortality.
In UK, the incidence of PD (20.58 per 100,000) in those aged
> 65 years was significantly higher than that in all aged adults
(Chalmers et al., 2016). In this study, chronic diseases and
malignant tumor were observed in most patients enrolled, which
indicated that chronic diseases and IC were two risk factors of
pneumococcal infection. As a previous study in the United States,
chronic liver disease and chronic obstructive pulmonary disease
(COPD) were the highest risk for IPD. For person with non-
IC chronic conditions, IPD risk increased with each additional
condition (Baxter et al., 2016). Immunosuppressed patients due
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TABLE 4 | Resistance rates of S. pneumoniae among different serotypes in Shanghai.
Serotype n PNSSPa (%) CXMa (%) CROa (%) FEPa (%) MEMa (%) ERYa (%) CLIa (%) AZMa (%) TCYa (%) SXTa (%) LEVa (%)
19F 15 66.67 100 6.60 20.00 80.00 100 100 100 100 100 13.33
3 12 0.00 0.00 0.00 0.00 0.00 66.67 33.33 66.67 58.33 0.00 0.00
23F 7 0.00 100 0.00 0.00 28.57 100 100 100 100 85.71 0.00
14 6 0.00 83.33 0.00 0.00 16.67 100 100 100 100 50.00 0.00
19A 4 50.00 100.00 0.00 0.00 75.00 100 100 100 100 75.00 0.00
6B 3 0.00 66.67 0.00 0.00 0.00 100 100 100 100 66.67 0.00
20 3 0.00 0.00 0.00 0.00 0.00 100 100 100 100 66.67 33.33
Others 20 0.00 5.00 0.00 0.00 0.00 95.00 80.00 90.00 80.00 35.00 5.00
untypeable 5 0.00 40.00 0.00 0.00 20.00 80.00 60.00 80.00 80.00 60.00 0.00
aPNSSP, penicillin-non-susceptible S. pneumoniae according to parenteral breakpoint of CLSI; CXM, cefuroxime; CRO, ceftriaxone; FEP, cefepime; MEM, meropenem; ERY,
erythromycin; CLI, clindamycin; AZM, azithromycin; TCY, tetracycline; SXT, trimethoprim/sulfamethoxazole; LEV, levofloxacin.
to immunosuppressive therapies and immunodeficiency were
also at risk of pneumococcal infection. The relative risk (RR) of
IPD could be multiplied by 20 to 50 in those with chemotherapy
or HIV (Kyaw et al., 2005). Therefore, the prevention of
pneumococcal infection in the population is crucial. Vaccines
are the most effective tool to reduce the mortality and economic
burden caused by pneumococcus (Naucler et al., 2017).
Since 2000, the 7-, 10-, and 13-valent pneumococcal conjugate
vaccines (PCV) and 23-valent pneumococcal polysaccharide
vaccines were introduced in many countries and reduced PD
burden dramatically (Pilishvili and Bennett, 2015). In China,
the 7-valent PCV were first licensed in 2008 and PCV13 and
PPV23 are currently on the market (Liang et al., 2016). Although
PCV13 has been listed in China, it has not been approved for
the elderly. The pneumococcal vaccine approved in China for
the elderly is PPV23. However, the overall vaccination rate is
still unclear in Shanghai. Only a survey reported that in Qingpu
district of Shanghai, the vaccination rate of 65–79 years old was
1.6%, the vaccination rate of 80 years old and above was 4.4% in
2014 (A Chinese Expert-workshop Recommendation for Elderly
Influenza and Pneumococcal Vaccination, 2018). According to
expert recommendation in China, PPV23 is recommended for
the elderly aged 60 years and above, and 1 dose for basic
inoculation. It is not recommended for the people with normal
immune function to be inoculated again. However, if there is
a risk factor for severe pneumococcal infection and the first
vaccination has been more than 5 years, another vaccination
is recommended. People aged 65 and over who have not been
vaccinated within 5 years (including those under 65 at the
time of the previous vaccination) may be vaccinated again. Due
to insufficient safety data for 3 or more doses of PPV23, it
is generally not recommended to vaccinate after the second
dose (A Chinese Expert-workshop Recommendation for Elderly
Influenza and Pneumococcal Vaccination, 2018). It was different
from the Centers for Disease Control and Prevention (CDC) of
the United States2. Although Shanghai has launched a project
since 2013 to vaccinate the elderly aged 60 years and above
with PPV23 free of charge, the overall vaccination rate in
elderly population was still unclear in recent years. As the
vaccination project progresses, the vaccination rate in elderly
2https://www.cdc.gov/vaccines/vpd/pneumo/hcp/PCV13-adults.html
population may have increased. In addition, the distribution of S.
pneumoniae capsular serotypes in a certain region are associated
with local status of vaccines (Akata et al., 2017). So seventy-five
S. pneumoniae isolates from adults were analyzed to reveal the
current prevalence state in Shanghai.
Usually, the introduction of vaccine was followed by a
decrease in the rate of vaccine serotype accompanied by an
increase in the diversity of non-vaccine serotype (Morales et al.,
2018). For example in Japan, PCV13 was licensed in 2013 and
the non-PCV13 serotype isolates increased significantly from
2012 to 2014 (Nakano et al., 2016). In a previous study of
China from 2011 to 2016, serotype 19F (25.7%), 19A (14.0%),
15 (6.8%), 6B (3.6%), 6A (3.0%), and 17 (2.8%) were prevalent
in adults. The prevalence of PCV7- and PCV13-serotypes were
37.5 and 58.3%, respectively (Zhao et al., 2017). The current
study showed that the prevalence of serotype 19 group decreased
while serotype 3 and 23F increased and the proportion of
PCV13-serotypes in Shanghai was higher (66.67%). In patients
≥ 65 years old, the prevalence of PCV7 and PCV10 targeting
serotypes were significant higher but those of PCV13 and PPV23
were not obviously different in adult-patients under and over
65y. Although PPV23 covered more serotypes than PCV13, the
proportion in current study had no significant difference (P =
0.0648> 0.05) in current study due to the prevalence of serotype
3 and 19A as a report from 2006 to 2016 (Lyu et al., 2017), The
current vaccines could still cover most serotypes of the strains
causing PD in adults, therefore, the vaccination rate in adult
population, especially in the elderly, need to be promoted in the
future. In addition, the epidemic data of S. pneumoniae from
children in Shanghai has been reported previously (Pan et al.,
2015). In this surveillance study, we found that the prevalence of
7-, 10-, and 13-valent PCV targeting serotypes were lower than
that in children (Pan et al., 2015; Zhao et al., 2019), and it seems
that PCV13 was more appropriate for pneumococcal infection
protection in children.
Penicillin is normally the first choice for PD treatment.
However, as the MIC value of penicillin increases, the breakpoint
of CLSI have changed based on the clinical data in 2008. The
former breakpoint categorizing susceptible, intermediate and
resistant were ≤0.06, 0.12–1, and 2µg/mL, respectively, which
are still valid for oral treatment with penicillin and same with the
EUCAST criteria. The new breakpoint, ≤2, 4, and 8µg/mL, has
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TABLE 5 | Resistance pattern of S. pneumoniae among different serotypes in Shanghai.
Serotype Number ST Resistance pattern
19F 15 271 (n = 13), 236, 14665 AMC-CRO-ERY-AZM-CLI-TCY-MEM-IPM-SXT-CEC-CXM (n = 2)
AMC-FEP-CRO-ERY-AZM-CLI-TCY-MEM-IPM-SXT-CEC-CXM (n = 2)
AMC-FEP-CRO-ERY-AZM-CLI-TCY-MEM-SXT-CEC-CXM (n = 5)
AMC-FEP-CRO-ERY-AZM-CLI-TCY-MEM-SXT-CEC-LEV-CXM
AMC-FEP-CRO-ERY-AZM-CLI-TCY-SXT-CEC-CXM
CRO-ERY-AZM-CLI-TCY-MEM-SXT-CEC-CXM
ERY-AZM-CLI-TCY-SXT-CEC-CXM FEP-CRO-ERY-AZM-CLI-TCY-SXT-CEC-CXM
FEP-ERY-AZM-CLI-TCY-MEM-MFX-SXT-CEC-LEV-CXM
3 12 180 (n = 6), 81 (n = 2), 505 (n = 2),
875, 4,655
non (n = 2) ERY-AZM (n = 2) ERY-AZM-CLI
ERY-AZM-CLI-TCY (n = 2) ERY-AZM-CLI-TCY-CEC-CHL
ERY-AZM-TCY (n = 2) TCY (n = 2)
23F 7 81 (n = 4), 180, 1,437, 3,942 ERY-AZM-CLI-TCY-SXT-CEC-CXM (n = 4) ERY-AZM-CLI-TCY-CEC-CXM
ERY-AZM-CLI-TCY-MEM-IPM-SXT-CEC-CXM
ERY-AZM-CLI-TCY-MEM-SXT-CEC-CXM
14 6 876 (n = 3), 15, 3,397, 8,561 ERY-AZM-CLI-TCY-CEC-CXM (n = 3) ERY-AZM-CLI-TCY-MEM-SXT-CEC-CXM
ERY-AZM-CLI-TCY-SXT
ERY-AZM-CLI-TCY-SXT-CEC-CXM
19A 4 320 (n = 4) AMC-ERY-AZM-CLI-TCY-IMP-CEC-CXM
AMC-ERY-AZM-CLI-TCY-MEM-IPM-SXT-CEC-CXM
ERY-AZM-CLI-TCY-MEM-SXT-CEC-CXM
AMC-ERY-AZM-CLI-TCY-MEM-IMP-SXT-CEC-CXM
6A/B 3 902, 982, 6,340 ERY-AZM-CLI-TCY-CEC-CXM
ERY-AZM-CLI-TCY-SXT
ERY-AZM-CLI-TCY-SXT-CEC-CXM
20 3 6,227, 4,745, 9,114 ERY-AZM-CLI-TCY-SXT-CEC-CXM
ERY-AZM-CLI-TCY-SXT
ERY-AZM-CLI-TCY-CEC
11A 2 99 (n = 2) ERY-AZM-TCY-SXT-LEV
ERY-AZM-CLI-TCY-SXT
15A 2 14,607, 11,792 ERY-AZM-CLI
ERY-AZM-CLI-TCY-CEC-CXM
16F 2 8,250 (n = 2) ERY-AZM-TCY
ERY-AZM-CLI-TCY
22F 2 11,185, 3,465 ERY-AZM-CLI
ERY-AZM-CLI-SXT-CHL
4 1 ERY-AZM-CLI-TCY-CHL
9V 1 ERY-AZM-CLI-TCY-SXT
5 1 ERY-AZM-CLI-TCY-CHL
10A 1 4,113 ERY-AZM-CLI-TCY-SXT
12F 1 386 ERY-AZM-CLI-TCY
15B/C 1 14,603 ERY-TCY
13 2 2,754, 11,955 ERY-AZM-CLI-TCY-SXT-CHL
ERY-AZM-CLI-TCY
34 1 11,964 ERY-AZM-CLI-TCY-CEC
35A(35C/42F) 1 7,751 ERY-AZM-CLI
35F 1 3,592 TCY
39 1 14,664 ERY-AZM-CLI-TCY-SXT
Untypeable 5 280, 8,356, 1,4,605, 14,606, 1,4697 ERY-AZM-CLI-TCY-SXT-CEC
ERY-AZM-CLI-TCY-CEC-CXM
ERY-AZM-CLI-TCY-MEM-SXT-CEC-CXM
NON
ERY-AZM-TCY-SXT
established for patients without meningitis but with intravenous
treatment (Hakenbeck et al., 2012). In this retrospective study,
we found that PNSSP isolates accounted for 16% based on
parenteral breakpoint, this rate would have been 52.00% based
on oral breakpoint, which was different from that previously
reported from Beijing, 8.0% for parenteral breakpoint and 91.6%
for oral breakpoint (Lyu et al., 2016). In addition, alterations
in the penicillin-binding proteins (PBPs) have been recognized
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as a major resistance mechanism in S. pneumoniae (Hakenbeck
et al., 2012). Altered PBP1a, PBP2x and PBP2b are the most
important PBPs for β-lactam resistance amongst clinical isolates.
It has been found that PBP2b mutation is mainly related to
penicillin resistance. And PBP2x mutation can lead to moderate
resistance to cephalosporins, while PBP1a mutation can cause
high levels of resistance to both penicillin and cephalosporins
(Cafini et al., 2006; Izdebski et al., 2008; Davies et al., 2012). In this
study, ceftriaxone-resistant isolates (17.33%) were not resistant to
penicillin and serotyped as 19F. PBPs mutation of these isolates
are required in further research.
The resistant rates of erythromycin, clindamycin,
azithromycin and tetracycline were higher than 80%. As
reported previously, the resistant rate of erythromycin in China
was the highest in Asia (Kim et al., 2012). No matter in children
or in adults, resistant rates of S. pneumoniae to erythromycin,
tetracycline and trimethoprim/sulfamethoxazole were high in
China (Yao and Yang, 2008; Zhao et al., 2017; Wang et al.,
2019), more serious than that in Europe (Yahiaoui et al., 2016).
Levofloxacin and moxifloxacin showed high susceptible rates
and no isolates were resistant to vancomycin and linezolid,
which was similar with reports in other regions in China
(Huang et al., 2015).
S. pneumoniae with multidrug-resistance (MDR, resistant to
three or more classes of antimicrobial) was widely existed in
clinical infection and greatly threaten the treatment of PD. The
incidence of MDR in invasive PD was higher than that in
non-invasive PD (Wang et al., 2019). In our study, 78.67% of
isolates showed MDR. According to a study from Asian Network
for Surveillance of Resistant Pathogens (ANSORP), the overall
S.pneumoniae MDR rate was 59.3%, with the highest MDR rate
83.3% in China (Kim et al., 2012). Vaccine-targeting serotypes
demonstrated higher resistance compared with uncovered
serotypes. In current study, antimicrobial resistant rate in the
most prevalent serotypes (19F, 19A, 14, and 23F) was higher
than other serotypes but serotype 3 was much more susceptible.
Extensive beta-lactam antibiotic resistance was observed more in
19F. In addition, From 2007 to 2013 in Canada, MDR rate of
was only 2.9% and 19F and 19A were also the most common
serotype for resistance to more than five antimicrobial classes
(Golden et al., 2015).
In previous report of China, CC271 was more common in
children, whereas singletons were more prevalent in adults,
and serotype 19F and 19A possessed the homogeneous genetic
background, together with high resistance to antibiotics (Zhao
et al., 2013). Themolecular analysis of S. pneumoniae in this study
showed that ST271, ST180, ST81, ST320, and ST876 were the top
five prevalent STs. CC271 was also prevalent in adults, accounted
for 25.33% (19/75).The serotype 19F-ST271 was dominating
and covered most PNSSP isolates as reported previously (Lyu
et al., 2016). The spread of international resistant clones
played a predominant role in increasing resistance in Shanghai.
The international clone complexes Taiwan19F-14, Spain23F-1,
Spain6B-2, and Taiwan23F-15 had been reported previously
in Shanghai (Yang et al., 2008). In our study, Taiwan19F-
14 was still predominant in the same region. However, the
prevalence of Netherland3-31 (ST180) clone was first reported.
The international resistance clone Netherland3-31 accounted for
10.67% of S. pneumoniae from adult, following the Taiwan19F-14.
In conclusion, serotype 19F, 3, 23F, 14, 19A targeted by
PCV13 and PPV23 were most prevalent in adult patients of
Shanghai associated with ST271, ST180, ST81, ST320, and
ST876. Taiwan19F-14 was predominant of three international
resistant clone complexes followed by Netherland3-31 (ST180)
clone, which was first reported in Shanghai. The incidence of
MDR was high and MDR existed in most isolates covered
by current vaccines. And the epidemiology of S. pneumoniae
requires further long-termed investigation on the basis of
this study.
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